If the response of medically trained psychiatrists to this challenge has not always been as impressive as it might be, one of their representatives has identified one major reason why this is so: 'The history of psychiatry', he remarks, 'belongs, so it is held, to the fringe of our discipline, and is too remote from the field of action, the clinic, the courtroom, or the research work to warrant much attention. It is best left to the older psychiatrist or the egghead blowing the dust off old books in secluded corners or Iibraries'V, This is clearly no longer a tenable position. Psychiatrists must enlarge their intellectual horizons if they are to keep abreast of modern historical scholarship, not only to satisfy academic standards but also because, as Henry Sigerist explained, 'to-day more than ever there is need also for medical interpretations and evaluations of the past of medicine ... Medical history teaches us where we came from, where we stand in medicine at the present time and in what direction we are marching. It is the compass that guides us into the future'P. To no branch of medicine is Sigerist's comment more applicable than psychiatry.
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Selling screening
Health screening involves a fundamental change in the traditional relationship between patient and doctor. The offering of screening to apparently fit people reminds them that they may not be as well as they feel. They are told or led to assume that earlier diagnosis or the discovery of an abnormality is desirable. However, these are usually only desirable if effective intervention is available and if that intervention is more efficacious when given before the arrival of symptoms. Here I shall only consider screening procedures to have efficacy where these criteria apply.
In therapeutic medicine there is an increasing tendency to demand objective evidence of benefit before the adoption of new treatments as routine, and in particular evidence from randomized controlled trials. Mere assumption of benefit on theoretical grounds is often not considered adequate justification.
For a few screening procedures, e.g. for phenylketonuria in neonates, for visual impairment in pre-school children 1 and for breast carcinoma in those over the age of 50 years 2 , there is incontrovertible evidence of an overall chance of benefit for each participant. However, the chance is always low and frequently extremely low. Furthermore, even screening of proven efficacy will carry disadvantage for some participants.
No such proof of an overall chance of benefit is available for the majority of screening techniques. This is largely because randomized controlled trials have not been performed, because the results of such trials are not available or are inconclusive (e.g, screening for colorectal carcinomas), or because the results that are available show no benefit (e.g. screening for lung cancer'), No randomized trials of screening for cervical carcinoma have been performed but the evidence for efficacy, from a wealth of international experience showing that the intensity of screening is correlated with mortality reduction, is now almost universally considered indisputable.
There may be little or no evidence of benefit even for those who are discovered to have a treatable abnormality. In a controlled trial of treatment for hypertension detected at screening, it was shown that if 850 mildly hypertensive patients aged 35-64 are given antihypertensive drugs for one year, about one stroke will be prevented. A substantial percentage of patients will experience chronic side effects and treatment does not appear to reduce overall mortality", Where the chance of benefit is very low, it may be outweighed by the chance of disadvantage. Disadvantage may result from psychologicalmorbidity arising from the knowledge of the presence of disease or a risk factor, or from a false-positive result. 'Abnormalities' in laboratory tests are usually defined as values falling two standard deviations from the mean, and thus 5% of the population will show 'abnormal' results on any single test for statistical reasons alone", Disadvantage may result from a false sense of security leading to the ignoring of symptoms arising after a clear screen. It may result from physical morbidity and even mortality due to the investigation itself, or from further invasive investigations which a positive screening test result may set in train. It is not inconceivable that a young woman could die from a laparoscopy or laparotomy following a falsepositive result from an ultrasound ovarian scan.
Admittedly the chance of substantial disadvantage is usually low,but if participants are being encouraged to seek a low chance of benefit, should not the potential disadvantages be made equally clear? Professor Rose has said that 'health promotion efforts must be honest and direct and not borrow the manipulatory techniques of advertisers", Where those involved in the offering of screening stand to benefit financially, it is particularly important that objectivity is retained. Health screening is now widely available in private hospitals in the United Kingdom. This reflects an increasing demand and enthusiastic marketing, both of which are built on the obvious popularity of the message that prevention is better than cure. Undoubtedly lives have been saved and it seems highly probable that there has been overall benefit. However, such benefit may be largely due to the inclusion of the very few screening procedures which are of established efficacy.
Not only should the claims made for screening programmes be balanced and objective,but prospective participants should be given the opportunity to be informed of the evidence for advantage from the testis) being offered and the approximate magnitude of the chance of any benefit. Should they not also be told routinely of the possibility of disadvantage as a result of participation, and that a clear screen is no guarantee of freedom from disease?
Such information may deter some potential participants, but a more objective approach could carry its own particular appeal for others. They might be more
